All Klebsiella pneumoniae articles
-
NewsWHO warns of widespread resistance to common antibiotics worldwide
One in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments, according to a new World Health Organization (WHO) report.
-
NewsNew Center of Excellence to respond to the challenge of antibiotic-resistant bacteria
Boston Children’s Hospital and Tulane University have received $25 million in funding from NIAID/NIH to establish a Center of Excellence for Translational Research (CETR) called IMPACT (Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity).
-
NewsStudy detects multidrug-resistant KPC-producing bacteria in Chilean wastewater for the first time
A team of Chilean researchers has identified, for the first time in the country, the presence of KPC-type carbapenemase-producing bacteria in wastewater samples from the Greater Concepción Metropolitan Area.
-
NewsNew sepsis diagnostic could reduce critical time to save patients
A new diagnostic method would confirm sepsis infections earlier, cutting critical hours in the “race against time” to save patients’ lives. The process uses a centrifuge to separate bacteria from blood cells, and automatic microscopy for detection.
-
NewsFighting infections with the power of the microbiome
Scientists have discovered that bacteria of the species Klebsiella oxytoca can displace pathogenic bacteria from the gut and want to develop a living biotherapeutic based on this finding. The DZIF is now providing 2.2 million euros in funding for product development.
-
NewsHospital superbugs that cause sepsis and meningitis could be hitching a ride on mobile phones
Hospital superbugs that cause sepsis and meningitis could be hitching a ride on mobile phones, allowing them to escape out of healthcare settings and into the community, according to research presented at MLS Future Forum earlier this year.
-
NewsFlightpath Biosciences licenses microbiome-sparing antibiotic developed at Illinois
Flightpath Biosciences, Inc., has licensed a class of antibiotics developed at the University of Illinois Urbana-Champaign. The original antibiotic agent, lolamicin, effectively treated bacterial infections in animal models of disease without wiping out beneficial gut microbes.
-
NewsGlobal action urgently needed to tackle antimicrobial resistance, experts warn
Scientists have called for urgent changes to the way new antibiotics are developed to address the growing problem of antimicrobial resistance (AMR). They outline the scientific, economic, and regulatory barriers that are slowing progress.
-
NewsShaken and stirred: why Klebsiella pneumoniae strain 007 poses a deadly threat
A new study has uncovered the secrets of a particular strain of the bacterium Klebsiella pneumoniae, revealing a potentially deadly genetic capacity for both antimicrobial resistance and virulence.
-
NewsAntibiotic resistance among key bacterial species plateaus over time
Scientists studying eight key bacterial species found that while antibiotic resistance initially rises in response to antibiotic use, it does not rise indefinitely. Instead, resistance rates reached an equilibrium over the 20-year period in most species.
-
NewsStudy uncovers the core principles of low-resistance antibiotics
Researchers have demonstrated that a dual-target approach, combining membrane disruption with an additional critical cellular pathway, significantly prevents the development of resistance in bacteria.
-
NewsScientists track pneumonia-causing bacteria as they infect the blood stream
A new study has shown various dissemination patterns can be adopted by Klebsiella pneumoniae that causes systemic infection, i.e. bacteremia.
-
NewsDangerous bacteria lurk in hospital sink drains, despite rigorous cleaning
Even in modern hospitals, drains can serve as reservoirs for known and novel pathogens, according to a new study.
-
NewsStudy finds diversity of deadly bacteria different in Saudi Arabia compared with rest of world
The largest epidemiology study ever of multidrug resistant Klebsiella pneumoniae in Saudi hospitals reveals a unique health strategy is required for Saudi Arabia.
-
NewsOvercoming resistance: McMaster researchers find new utility for old antibiotics
In a recent study, researchers found that zinc plays a vital role in how some of the world’s most dangerous bacteria resist antibiotics.
-
NewsPandrug-resistant bacteria from the war in Ukraine are extremely pathogenic
Using samples from 141 war-wounded it was shown that several bacteria types were resistant to broad-spectrum antibiotics and that six per cent of samples were resistant to all antibiotics that the researchers tested.
-
NewsMeningitis has a much greater impact on child mortality than previously thought
New study reveals high rates of antibiotic-resistant bacteria in hospital-associated cases of meningitis in children under five years of age.
-
NewsReducing antimicrobial resistance: accelerated efforts are needed to meet the EU targets
Marking European Antibiotic Awareness Day on 18 November and the start of World Antimicrobial Resistance Awareness Week, ECDC presents new data on antimicrobial consumption and resistance.
-
NewsMultidrug-resistant bacterium posing a global public health threat is detected in Northeast Brazil
A strain of Klebsiella pneumoniae that is resistant to all available antibitoics has been detected in Brazil after previously being detected in the United States.
-
NewsBreaking down bacterial barriers using bovine gut enzyme
A team of scientists has devised a way to break down biofilms which limit the entry of drugs and help bacteria become resistant to antibiotics, using an enzyme from the cow’s digestive tract.